The Impact of SARS-CoV-2 on Inflammatory Bowel Disease

Simple item page
dc.contributor.authorMaría Manuela Estevinho
dc.contributor.authorFernando Magro
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:12:27Z
dc.date.available2026-03-22T21:12:27Z
dc.date.issued2020
dc.descriptionCitaciones: 4
dc.identifier.doi10.1159/000508114
dc.identifier.urihttps://doi.org/10.1159/000508114
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/86567
dc.language.isoen
dc.publisherKarger Publishers
dc.relation.ispartofGE Portuguese Journal of Gastroenterology
dc.sourceUniversidade do Porto
dc.subjectMedicine
dc.subjectInflammatory bowel disease
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subject2019-20 coronavirus outbreak
dc.subjectInflammatory Bowel Diseases
dc.subjectCoronavirus Infections
dc.subjectDisease
dc.subjectIntensive care medicine
dc.titleThe Impact of SARS-CoV-2 on Inflammatory Bowel Disease
dc.typeeditorial

Files

Collections

Artículo Científico Publicado